Richardson Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$420K Buy
1,605
+426
+36% +$109K 0.24% 99
2026
Q2
$297K Sell
1,179
-305
-21% -$65.6K 0.17% 124
2026
Q1
$323K Sell
1,484
-195
-12% -$43.3K 0.2% 117
2025
Q4
$384K Buy
1,679
+24
+1% +$5.47K 0.12% 104
2025
Q3
$383K Buy
1,655
+149
+10% +$30.3K 0.24% 98
2025
Q2
$286K Sell
1,506
-12
-0.8% -$2.23K 0.19% 127
2025
Q1
$318K Buy
1,518
+264
+21% +$51.3K 0.24% 113
2024
Q4
$221K Sell
1,254
-2
-0.2% -$368 0.16% 128
2024
Q3
$216K Buy
1,256
+6
+0.5% +$1.12K 0.14% 144
2024
Q2
$214K Sell
1,250
-59
-5% -$9.8K 0.15% 132
2024
Q1
$238K Buy
1,309
+45
+4% +$7.76K 0.17% 130
2023
Q4
$196K Buy
+1,264
New +$184K 0.17% 128

Other funds holding ABBV

Richardson Financial Services's ABBV Position: Q3 2026 in Review

Richardson Financial Services increased its AbbVie (ABBV) stake by 36% in Q3 2026, buying an estimated $109K and bringing the position to 1,605 shares worth $420K. The position accounts for 0.24% of the portfolio, ranked #99.

Richardson Financial Services first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Richardson Financial Services held 1,605 shares of AbbVie worth $420K as of Q3 2026.
  • Richardson Financial Services bought 426 AbbVie shares in Q3 2026, an estimated $109K.
  • AbbVie made up 0.24% of Richardson Financial Services's portfolio in Q3 2026, its #99 holding.
  • Richardson Financial Services first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Richardson Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.